ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Zura Bio Limited (NASDAQ: ZURA) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Form SC 13G/A Zura Bio Ltd Filed by: Venrock Healthcare Capital Partners III, L.P.
Form SC 13G/A Zura Bio Ltd Filed by: GREAT POINT PARTNERS LLC
Form SC 13G Zura Bio Ltd Filed by: ADAR1 Capital Management, LLC
Form 8-K Zura Bio Ltd For: Nov 14
Form SC 13G/A Zura Bio Ltd Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.